Indinavir
Crixivan (indinavir) is a small molecule pharmaceutical. Indinavir was first approved as Crixivan on 1996-03-13. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections. Crixivan's patent is valid until 2021-02-10 (FDA).
| Trade Name | Crixivan |
|---|---|
| Common Name | Indinavir |
| Indication | acquired immunodeficiency syndrome, hiv infections |
| Drug Class | Antivirals: HIV protease inhibitors (saquinavir type) |
